We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

THERMO FISHER SCIENTIFIC

  Gold Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Sep 2021 - 25 Sep 2021

Lipid Metabolism Affects GBA-Associated Parkinson's Disease

By LabMedica International staff writers
Posted on 13 Aug 2021
Print article
The Applied Biosystems 3500xL Genetic Analyzer (Photo courtesy of Thermo Fisher Scientific).
The Applied Biosystems 3500xL Genetic Analyzer (Photo courtesy of Thermo Fisher Scientific).
Parkinson’s disease (PD) is the most common neurodegenerative disorder after Alzheimer’s disease. The pathognomonic hallmark of PD is the degeneration of dopaminergic neurons of the substantia nigra and, consequently, the striatal dopamine depletion.

Brain cholesterol metabolism has been described as altered in PD patients. Plasma 24-OH-cholesterol has been considered as a possible biomarker for PD. Several genes have been associated with the familial forms of PD. The identification of these genes and their mechanisms provides an insight into PD etiopathology.

Neuroscientists at the Universidad de Sevilla (Seville, Spain) and their colleagues, included in a study included 403 PD patients (342 sporadic PD patients, 30 glucocerebrosidase (GBA)-associated PD patients, and 31 Leucine-rich repeat kinase 2 gene (LRRK2) -associated PD patients) and 654 healthy controls (HCs). The team measured Total cholesterol (TC), high-density lipoprotein (HDL), low-DL (LDL), and triglycerides in peripheral blood.
Genomic DNA was isolated from peripheral blood samples by standard or automated methods, DNA Isolation Kit for Mammalian Blood, MagNA Pure LC, (Roche Life Science, Indianapolis, IN, USA); or Maxwell 16 System, (Promega Corporation, Madison, WI, USA). High-resolution melting (HRM) analyses were performed on a LightCycler480 (Roche Diagnostics, Rotkreuz, Switzerland). Samples showing abnormal melting profiles, including those with variants, were sequenced on both strands using the BigDye terminator cycle sequencing kit (Applied Biosystems, Foster City, CA, USA) and resolved on an ABI3500 genetic analyzer.

The scientists reported differences in TC and triglycerides levels between groups were statistically significant after adjusting for age and sex. There were no significant differences in HDL levels between PD patients and HCs. Multivariate ANCOVA revealed significant differences among the groups within cholesterol and LDL levels. GBA-associated PD patients had significantly lower levels of total cholesterol and LDL compared to LRRK2-associated PD patients and HCs. The different serum cholesterol levels in GBA-associated PD might be related to diverse pathogenic mechanisms. LRRK2-PD patients had the highest levels of both TC and LDL (213.73 ± 30.01 mg/dL and 141.09 ± 30.48 mg/dL, respectively).

The authors concluded that their results show that GBA-associated PD patients have different serum lipid profiles, and support the hypothesis of lipid metabolism disruption as one of the main pathogenic mechanisms in GBA-associated PD. The study was published on July 16, 2021 in the journal npj Parkinson's Disease.

Related Links:

Universidad de Sevilla 
Roche Life Science
Promega Corporation 
Roche Diagnostics 
Applied Biosystems

New
Gold Supplier
Benchtop Auto Sample Transfer Processor
MGISTP-3000
New
Silver Supplier
Automated Nucleic Acid Extractor
NE48/96
New
Silver Supplier
Automated Body Fluid Cell Count Control
Cell-Chex Auto
New
Urea Breath Test System for H. Pylori
BreathID Hp Lab

Print article

Channels

Pathology

view channel
Image: The CellSearch Circulating Tumor Cell Kit is intended for the enumeration of circulating tumor cells of epithelial origin (CD45-, EpCAM+, and cytokeratins 8, 18+, and/or 19+ and PD-L1) in whole blood (Photo courtesy of CellSearch/Menarini Silicon Biosystems)

PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC

In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the... Read more

Industry

view channel
Illustration

Global Digital Polymerase Chain Reaction (dPCR) Market Projected to Reach Close to USD 1.15 Billion by 2028

The global digital polymerase chain reaction (dPCR) market is projected to grow at a CAGR of more than 9% from over USD 0.50 billion in 2020 to nearly USD 1.15 billion by 2028, driven primarily by rising... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.